Provident Financial PLC
07 March 2008
Directors'/PDMRs' interest in shares - Provident Financial Long Term Incentive
Scheme
Provident Financial plc announces that Kleinwort Benson (Jersey) Trustees
Limited, as Trustees of the Provident Financial plc 2007 Employee Benefit Trust
('the Trust'), purchased 775,066 ordinary shares of 20 8/11p each at an average
price of £8.31715 per share on 5 and 6 March 2008 to satisfy potential awards to
be made under the Provident Financial Long Term Incentive Scheme 2006
('Scheme').
The Trust is a discretionary employee benefit trust and may benefit employees of
Provident Financial plc and its subsidiaries at the discretion of the Trustee.
Accordingly, it is noted that the following directors and PDMRs, as potential
beneficiaries under the Trust, have an interest in the shares acquired by the
Trust:
Peter Crook
Andrew Fisher
Chris Gillespie
Michael Lenora
David Merrett
John Moulding
Ken Mullen
Emma Versluys
Deputy Company Secretary
01274 731111 ext. 2569
7 March 2008
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.